Qualigen Therapeutics Inc (QLGN)
0.301
+0.01
(+3.69%)
USD |
NASDAQ |
May 03, 16:00
0.3067
+0.01
(+1.89%)
After-Hours: 20:00
Qualigen Therapeutics Max Drawdown (5Y): 99.91% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.91% |
| March 31, 2024 | 99.91% |
| February 29, 2024 | 99.91% |
| January 31, 2024 | 99.91% |
| December 31, 2023 | 99.91% |
| November 30, 2023 | 99.91% |
| October 31, 2023 | 99.91% |
| September 30, 2023 | 99.91% |
| August 31, 2023 | 99.91% |
| July 31, 2023 | 99.91% |
| June 30, 2023 | 99.91% |
| May 31, 2023 | 99.91% |
| April 30, 2023 | 99.91% |
| March 31, 2023 | 99.91% |
| February 28, 2023 | 99.89% |
| January 31, 2023 | 99.89% |
| December 31, 2022 | 99.89% |
| November 30, 2022 | 99.89% |
| October 31, 2022 | 99.89% |
| September 30, 2022 | 99.89% |
| August 31, 2022 | 99.89% |
| July 31, 2022 | 99.89% |
| June 30, 2022 | 99.89% |
| May 31, 2022 | 99.89% |
| April 30, 2022 | 99.89% |
| Date | Value |
|---|---|
| March 31, 2022 | 99.89% |
| February 28, 2022 | 99.89% |
| January 31, 2022 | 99.89% |
| December 31, 2021 | 99.89% |
| November 30, 2021 | 99.89% |
| October 31, 2021 | 99.87% |
| September 30, 2021 | 99.87% |
| August 31, 2021 | 99.87% |
| July 31, 2021 | 99.83% |
| June 30, 2021 | 99.83% |
| May 31, 2021 | 99.83% |
| April 30, 2021 | 99.80% |
| March 31, 2021 | 99.71% |
| February 28, 2021 | 99.69% |
| January 31, 2021 | 99.69% |
| December 31, 2020 | 99.69% |
| November 30, 2020 | 99.69% |
| October 31, 2020 | 99.69% |
| September 30, 2020 | 99.69% |
| August 31, 2020 | 99.69% |
| July 31, 2020 | 99.69% |
| June 30, 2020 | 99.69% |
| May 31, 2020 | 99.69% |
| April 30, 2020 | 99.69% |
| March 31, 2020 | 99.69% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.05%
Minimum
May 2019
99.91%
Maximum
Mar 2023
99.76%
Average
99.88%
Median
Max Drawdown (5Y) Benchmarks
| Marizyme Inc | 99.92% |
| CEL-SCI Corp | 96.13% |
| AIM ImmunoTech Inc | 99.76% |
| IGC Pharma Inc | 97.77% |
| NovaBay Pharmaceuticals Inc | 99.91% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -66.49 |
| Beta (5Y) | -0.7313 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 90.83% |
| Historical Sharpe Ratio (5Y) | -0.8217 |
| Historical Sortino (5Y) | -1.514 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.14% |